An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis

INTRODUCTION: Multiple sclerosis (MS) is an immune-mediated disorder of the CNS manifested by recurrent attacks of neurological symptoms (related to focal inflammation) and gradual disability accrual (related to progressive neurodegeneration and neuroinflammation). Sphingosine-1-phosphate-receptor (...

Descripción completa

Detalles Bibliográficos
Autores principales: Dumitrescu, Laura, Papathanasiou, Athanasios, Coclitu, Catalina, Garjani, Afagh, Evangelou, Nikos, Constantinescu, Cris S., Popescu, Bogdan Ovidiu, Tanasescu, Radu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069376/
https://www.ncbi.nlm.nih.gov/pubmed/36946625
http://dx.doi.org/10.1080/14656566.2023.2178898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069376/
https://www.ncbi.nlm.nih.gov/pubmed/36946625
http://dx.doi.org/10.1080/14656566.2023.2178898

Ejemplares similares